Showing 5 results for Vaccination
A Moradi, A Abbasi, Ar Mansourian, A Ahmadi, A Sarikhani, M Bazoori,
Volume 1, Issue 2 (10-2007)
Abstract
Abstract: Introduction: Influenza is highly transmitted disease and vaccination is the most effective way to prevent influenza. This research was designed to study the variation of serum antibody level among the subjects had already been vaccinated against influenza. Materials and Methods: This research is a descriptive-analytical study, which was carried out on 196 subjects who had influenza vaccination (influvac 2005/2006) and 200 subjects matched by the vaccinated subjects, by age. The subject's serums were prepared seven weeks after influenza vaccination, and the control group's serums were also prepared. The serum antibody level was determined by haemaglutination inhibition test. Results: The mean age of case group is 52.2±11 and control group 48.64±5.17.The antibody titre of 115 of Vaccinated group and 15 of control is less than 40 1 The mean antibody titer of vaccinated subjects and control group is 143.4 ± 10.89 and 18.34± 3.2, respectively. The difference is statistically significant (P value=0.000). Conclusion: The findings show that the mean titer of antibody in vaccinated and control group is statistically different. It means that the influenza vaccine had a good efficacy. Key words: Vaccination, Influenza, Gorgan.
A Ghazavi, M Khaki, N Mosakhani,
Volume 3, Issue 1 (4-2009)
Abstract
Abstract Background and objectives: Since Rubella is an infectious disease with a few clinical symptoms, it is hardly diagnosed. Especially in the first trimester of pregnancy, congenital rubella is one of the major causes of neonatal mortality and permanent disablement in children. The aim of this study was to determine the sero immunity Level of The single Female student's after national rubella vaccination program in Iran. Material and Methods: This descriptive seroepidemiologic study was conducted on 129 single medical students. After taking written consent form, blood Sample was drawn. The anti-rubella IgG titer was evaluated using ELISA method. Statistical analysis was performed using SPSS (version10). Results: All Subjects had protective titer of anti-rubella antibodies. One hundred and eighteen students (91.5%) were immunized by taking rubella vaccine in the national vaccination program and only 11(8.5%) students reported that they suffered from natural rubella infection in the past. Conclusion: Based on the results of our study, vaccination against rubella in national vaccination program along with natural immunity caused by natural rubella infection in children could produce a protective immunity against rubella. Key words: Rubella, ELISA, vaccination, medical students
S Shojaee, F Hosseine, N Fakhr-E-Rad, B Bijaree, M Sekhavati, M Fereidouni,
Volume 7, Issue 2 (7-2013)
Abstract
Abstract
Background and Objective: Having knowledge about potential risks and the usage of safety equipment in laboratories can decrease the risk of occupational exposure. The aim of this study was to evaluate the predisposing factors for occupational exposure and to assess the usage of safety equipment among personnel of medical diagnostic laboratories in Birjand.
Material and Methods: In this descriptive analytic study, all staff of laboratories was assessed by using a questionnaire including demographic data, type of accidental exposures and the use of protective equipment. Using SPSS software, we analyzed the data.
Results: Of 110, 84 (76%) have at least one accidental exposure to patients’ specimens in that 55% of accidents are related to sample preparation step. In 82% of contacts, carelessness is the underlying cause of exposure. Gown, glove, fume hood and mouth mask are routinely used by 97%, 48%, 34%, 1% of personnel, respectively. Nearly all of (97%) personnel were vaccinated against hepatitis B and 78% of them have performed routine blood test for detecting any infections.
Conclusion: The results of current study show that accidental exposures to patients’ samples are common among personnel of medical diagnostic laboratories. The level of preventive education and the rate of safety equipment usage are low therefore, we recommend planning of some training sessions to persuade the personnel for using safety equipment.
Keywords: Medical laboratory, Occupational Exposure, Specimens, Vaccination
Ommolbanin Younesian, Behnaz Khodabakhshi, Sara Hosseinzadeh, Seyedeh Somayeh Hosseini Alarzi, Samareh Younesian, Mojtaba Pourmomen, Mana Zakeri, Ali Hosseini, Professor Hamidreza Joshaghani,
Volume 17, Issue 5 (9-2023)
Abstract
Background: Although public health interventions have slowed the spread of SARS CoV 2 infections, the worldwide pandemic of COVID 19 is progressing. Thus, effective and safe vaccination against SARS CoV 2 is an important tool for controlling the COVID 19 pandemic. Now in the early stages of COVID 19 vaccination, vaccinated individuals are interested in using antibody tests to confirm vaccination success and estimate the time of protection. Here, we assessed anti spike IgG responses in the general population 2 weeks after the second dose of the Sputnik V vaccine.
Methods: This study included blood samples of 67 individuals without a previous SARS CoV 2 infection taken 14 days after the second dose of the Sputnik V vaccine. Anti spike IgG responses were assessed with an enzyme linked immunosorbent assay (ELISA).
Results: Anti spike IgG was detected in 55 (82.1%) of 67 samples 14 days after the second dose of the Sputnik V vaccine. Antibody levels were significantly lower in males than in females, and 9 (75%) of 12 seronegative individuals were males.
Conclusion: Vaccination resulted in detectable anti spike IgG in 82.1% of individuals, and gender may be an important factor in the humoral response.
Udhaya Kumar, Anirudh Mutalik, Jeevithan Shanmugam, Mohan Kumar,
Volume 18, Issue 1 (1-2024)
Abstract
Background: Viral hepatitis is increasingly being recognized as a public health problem, requiring special attention. The World Health Organization (WHO) estimated that in 2019, 296 million people globally (3.8%) had chronic hepatitis B virus (HBV) infection, and 58 million people (0.8%) were living with hepatitis C virus (HCV). To add to this, every year, about 1.5 million people are newly infected with either hepatitis B or C viruses. The Global Health Sector Strategy (GHSS) has aimed to eliminate viral hepatitis as a major public health problem by 2030.
Methods: We conducted a desk review to identify strategies for preventing viral hepatitis and develop a roadmap to attain the sustainable development goals (SDG) target by 2030 (particularly in low- and middle-income countries). A search was done in PubMed via Medline on 1 December 2022.
Results: The focus has to be on key interventions, including hepatitis B vaccination (part of the routine child immunization along with rescheduling the birth dose to up to 7 days post-term, adult vaccination, for targeted groups like health care providers, rag pickers, waste handlers, and sanitation workers), ensuring safe injection practices and blood transfusion, harm reduction interventions for people who inject drugs (PWID), adequate testing for early diagnosis, and ensuring appropriate treatment.
Conclusion: It is the need of the hour to prioritize key interventions identified in the review for preventing viral hepatitis.
